Artículo de revisión
Published on 8 de abril de 2025 | http://doi.org/10.5867/medwave.2025.03.2938
Oral and oropharyngeal colonization by Enterobacteriaceae: A narrative review on its epidemiology and clinical impact
Back to article
Set of included studies and eligible variables.
Costa C et al., 2021 [ | 87 | Not specified | Not specified | Saliva collection | MALDI-TOF | 43.20% | - | Amoxicillin 83%, sulfamethoxazole 43%, ciprofloxacin 35%, streptomycin 17% | |
Leão-VasconcelosL et al., 2015 [ | 294 | Not specified | F, M (Lack of quantitative distribution) | Sample of unstimulated saliva | Gram stain, biochemical screening, and classification tests (indole production; presence of motility; ornithine, arginine, and lysine decarboxylation) | 18.70% | - | Amoxicillin/clavulanic acid 57.8% | |
Valenti WM et al., 1978 [ | 407 | > 65 | F:294 | Oropharyngeal culture by throat swab | Agar Mac Conkey | - | 40% | - | |
Le MN-T et al., 2020 [ | 98 | 55 to 101 | F:69 | Oropharyngeal swab | Vitek-2 system, 16S rDNA sequencing, and MALDI-TOF MS-Biotyper | - | 38% | Ampicillin 100%, piperacillin 12.5%, cefazolin 62. 25%, ceftazidime 37.5%, cefotaxime 37.5%, cefozopran 12.5%, cefpodoxime 37.5%, ciprofoxacin 12.5%, fosfomycin 25% | |
Atarashi K et al., 2017 [ | - | - | - | Saliva samples from two patients with Crohn’s disease were transferred to germ-free mice | - | - | - | - | - |
Chinnasamy A et al., 2019 [ | 150 | 6 to 17 | F: 104 | Mouthwash samples with 10 ml of phosphate-buffered saline | Blood agar and MacConkey plus Vitek 2 system | 72% | - | - | |
Kamal FG, Bernard RA, 2015 [ | 100 | 8 to 15 | Not specified | Sample of mouthwash with 10 ml of phosphate-buffered saline solution | Culture media: MacConkey agar and blood agar. Oxidase test, indole test, methyl red test, Voges-Proskauer test. | 42% onychophagy, 30% digital suction | - | - | |
Conti S et al., 2009 [ | 100 | 30 to 50 | F: 50 | Samples of plaque collected from the dorsum of the tongue in the circumvallate papillae region | Agar MacConkey plus API 20E system | 43% on the back of the tongue | - | - | |
Baydas B. et al., 2007 [ | 59 | 11.9 and 16.5 | F: 35 | Mouthwash samples with 10 ml of phosphate-buffered saline solution | MacConkey agar and blood agar | 47.46% | - | ||
Goncalves M. et al., 2007 [ | 80 | 35 and 60 | F: 36 | Paper-tip samples inserted in periodontal pockets | MacConkey agar CLED agar | - | - | Ampicillin 75%, amoxicillin/clavulanic acid 25%, aminoglycosides 5%, tetracycline 25%, sulfamethoxazole/trimethoprim 5% and chloramphenicol 8%. | |
Hägg U et al., 2004 [ | 50 | average age 15.5 ± 2.4 | F: 26 | Mouthwash with 10 ml of phosphate-buffered saline solution and the combined plaque method | MacConkey agar and blood agar | 23.40% | - | - | |
Pathak A, Sharma D, 2013 [ | 25 | 10 and 14 | Not specified | The retainers were placed in 10 ml of phosphate-buffered saline solution | Candida Hichrome agar, eosin methylene blue agar, UTI Hichrome agar, tryptone glucose yeast extract agar, blood base agar medium | - | - | - | Not specified |
Sreela LS et al., 2017 [ | 100 | Not specified | Not specified | Mouthwash samples with 10 ml of phosphate-buffered saline solution | Agar blood and agar Mac Conkey | 58% | - | Amoxicillin 80%, cephalexin 70%, amoxicillin-clavulanic acid 70%, cefotaxime 63% and ceftriaxone 63% | |
Pontes L et al., 2022 [ | 362 | ≥ 18 | Not specified | Subgingival biofilm samples with sterile curettes in the most apical portion of the sulcus/pocket | Plates with selective agar for gram-negative bacilli | 36.20% | - | Cefoxitin 50.9%, amoxicillin-clavulanate 43.3%, cefazolin 42.9% | |
Jepsen K et al., 2022 [ | 16.612 | 11 and 89 | Not specified | Samples of deep periodontal pocket biofilms | Sheep blood agar, lactose blue agar, and Kimmig agar | 5% | - | Amoxicillin/clavulanic acid 79.1%, doxycycline 37.7% | |
Vieira A et al., 2016 [ | 270 | ≥ 18 | Not specified | Samples of subgingival biofilm from 7 healthy sites, 7 sites with periodontitis; 7 sites with gingivitis | 40% | - | - |
Abbreviations, MALDI-TOF. matrix-assisted laser desorption/ionization. MDR-E, multidrug-resistant enterobacteria. 16S rDNA, 16S ribosomal DNA. OP, oropharynx. M, male. F, female.
Source: Prepared by the authors based on study results.